Comparison of pitavastatin with simvastatin in primary hypercholesterolaemia or combined dyslipidaemia

Leiv Ose, Dragos Budinski, Neil Hounslow, Valerie Arneson

Current Medical Research and Opinion · 2009 · 84 citations · 27 references

Abstract

As compared with simvastatin, an established first-line lipid-lowering agent, pitavastatin is an efficacious treatment choice in patients with primary hypercholesterolaemia or combined dyslipidaemia.

References

27